glp 1 for diabetes GLP-1 Agonists - What is it? GLP-1-based therapies for diabetes, obesity
Description
CuthbertsonDJIrwinAGardnerCJDaousiCPurewalTFurlongNet al

Much evidence suggests that activation of anorexogenic proopiomelanocortin (POMC) neurons and simultaneous inhibition of orexigenic neuropeptide Y/Agouti-related peptide (NPY/AgRP) neurons in the ARC appears to be one of the major mechanisms for GLP-1R mediated inhibition of food intake

Injecting through wet alcohol stings

1995;310(Pt 1):203214

Lancet 2021, 398, 18111824

September 9, 2024
